Zinc transporter-1 concentrates at the postsynaptic density of hippocampal synapses
© Sindreu et al.; licensee BioMed Central Ltd. 2014
Received: 29 January 2014
Accepted: 28 February 2014
Published: 7 March 2014
Zinc concentrates at excitatory synapses, both at the postsynaptic density and in a subset of glutamatergic boutons. Zinc can modulate synaptic plasticity, memory formation and nociception by regulating transmitter receptors and signal transduction pathways. Also, intracellular zinc accumulation is a hallmark of degenerating neurons in several neurological disorders. To date, no single zinc extrusion mechanism has been directly localized to synapses. Based on the presence of a canonical PDZ I motif in the Zinc Transporter-1 protein (ZnT1), we hypothesized that ZnT1 may be targeted to synaptic compartments for local control of cytosolic zinc. Using our previously developed protocol for the co-localization of reactive zinc and synaptic proteins, we further asked if ZnT1 expression correlates with presynaptic zinc content in individual synapses.
Here we demonstrate that ZnT1 is a plasma membrane protein that is enriched in dendritic spines and in biochemically isolated synaptic membranes. Hippocampal CA1 synapses labelled by postembedding immunogold showed over a 5-fold increase in ZnT1 concentration at synaptic junctions compared with extrasynaptic membranes. Subsynaptic analysis revealed a peak ZnT1 density on the postsynaptic side of the synapse, < 10 nm away from the postsynaptic membrane. ZnT1 was found in the vast majority of excitatory synapses regardless of the presence of vesicular zinc in presynaptic boutons.
Our study has identified ZnT1 as a novel postsynaptic density protein, and it may help elucidate the role of zinc homeostasis in synaptic function and disease.
Homeostasis of ionic or labile zinc (Zn2+) in central neurons might be important in a range of physiological and pathological events. Zn2+ may act as a co-transmitter at certain glutamatergic synapses, participate in neuronal signal transduction, modulate memory formation and nociception, or promote neurodegeneration upon brain insults [1, 2]. Marked differences in the levels of intracellular Zn2+ are found among cellular compartments owing to the coordinated actions of two families of zinc transporter proteins, Slc30a (ZnT1-10) and Slc39 (ZIP1-14). Whereas ZnTs export Zn2+ away from the cytosol into organelles or the extracellular space, ZIPs shuttle Zn2+ in opposite direction . Cytosolic Zn2+ is estimated to be in the subnanomolar range, but Zn2+ transients in neurons have been reported following strong depolarization or oxidation . Accumulation of cytosolic Zn2+ is common in degenerating neurons in models of epilepsy, ischemia or Parkinson’s disease [5–7]. In contrast, high concentrations of zinc are normally found at synapses . Bound zinc maintains the organization of the postsynaptic density (PSD) , where it associates with Shank2/3 protein scaffolds  and SAP-102 . In addition, a subset of excitatory boutons up-take Zn2+ into glutamatergic vesicles via ZnT3 . One may expect, therefore, that specific plasma membrane proteins support Zn2+ homeostasis at synapses, but their identity remains elusive. One candidate protein is ZnT1 . ZnT1 localizes to the plasma membrane, reduces cytosolic Zn2+, confers resistance against Zn2+ toxicity, and it is expressed in several brain regions [13, 14]. We previously developed a protocol that allows for the co-localization of neuronal proteins and vesicular Zn2+ by combining immunogold electron microscopy with zinc histochemistry . Here we used a similar approach to ask whether ZnT1 localizes to synapses. We focused on the CA1 region of the hippocampus because only half of CA3-to-CA1 synapses contain vesicular Zn2+, allowing for direct comparisons between the presence of vesicular Zn2+ and ZnT1 expression.
Results and discussion
ZnT1 is found in synaptic regions in hippocampus
ZnT1 concentrates at the postsynaptic density
Synaptic ZnT1 labeling was widespread, encompassing 76 ± 3% of asymmetric synapses in single ultrathin sections (3.2 ± 1.7 particles/synapse; range 1–9; n = 175 synapses). Particle distribution along the axis perpendicular to the synaptic junction revealed a main peak on the cytoplasmic side of the postsynaptic membrane (7.1 ± 0.8 nm from the membrane; n = 339 particles and 132 synapses) (Figure 2F). Further, tangential analysis of synaptic ZnT1 revealed a moderate lateral increase along the PSD length (n = 111 particles and 46 synapses; Figure 2G). The results indicate that ZnT1 concentrates in the postsynaptic membrane of hippocampal synapses, in keeping with the biochemical data.
Synaptic ZnT1 expression and vesicular Zn2+
The present results provide compelling evidence that ZnT1 is preferentially expressed in synaptic membrane domains in rodent hippocampus (mouse and rat), and identify ZnT1 as a novel PSD protein. ZnT1 was found in the somatodendritic compartment in region CA1, it co-localized with PSD proteins GluR1 and SynGAP in dendritic spine-like structures, and it was enriched in synaptic membrane fractions compared with extrasynaptic membrane. High-resolution immunogold electron microscopy confirmed and extended these results, showing that ZnT1 densities were over 5-fold higher in postsynaptic junction membranes than in other membrane domains, including extrasynaptic spine membrane, shafts, boutons, somata or astrocytes. Furthermore, the ZnT1 particle distribution across the synapse, peaking within 10 nm inside the postsynaptic membrane, suggests that ZnT1 is an integral transmembrane protein at the PSD, which is consistent with the predicted 6 hydrophobic regions in its aminoacid sequence . The fact that ZnT1 surface density was similarly low among several extrasynaptic regions suggests that, in addition to the secretory pathway targeting ZnT1 to the cell surface, a synapse-specific mechanism may retain ZnT1 at the PSD. One possibility is that ZnT1 interacts via its cytoplasmic regions with other PSD proteins to concentrate at synapses. Interestingly, ZnT1 is the only member of its family that presents a consensus PDZ Class I motif at its C-terminus (Figure 3D), the latter showing 100% identity in humans. Several scaffolding molecules recognize PDZ motifs, including PSD-95, MPP1 or Lin7. Since the ZnT1 PDZ motif (ESSL) is very similar to that of GluN2A/B (ESDV), one may speculate that proteins of the PSD-95 family may also be retaining ZnT1 at the PSD.
Notably, ZnT1 was not restricted to the subset of synapses containing vesicular Zn2+. This widespread distribution implies a general physiological role for ZnT1 at synapses independently of the actions of ZnT3 or vesicular Zn2+. Accordingly, organizing synaptic scaffolds appear particularly sensitive to intracellular Zn2+, leading to changes in PSD morphology upon zinc chelation . It is therefore possible that zinc status itself affects ZnT1 localization or expression. ZnT1 may be responsible for counteracting basal ZIP-mediated influx of interstitial Zn2+ or for removing Zn2+ liberated in dendrites from redox-sensitive metalloproteins, such as metallothionein-3 or PKC [18, 19]. In keeping with this, deletion of metallothionein-3 prevents the build-up of cytosolic Zn2+ following seizures . Additional roles for ZnT1 besides Zn2+ transport, such as modulation of MAPK or Ca2+ signaling [21, 22], or targeting of potential PSD protein partners, cannot be ruled out. Genetic deletion of ZnT1 is embryonic lethal . Given the high concentration of elemental zinc and ZnT1 at PSDs, it will be interesting to learn how conditional deletion of ZnT1 affects synaptic structure and function.
ZnT1 is the first zinc transporter protein shown to concentrate at the PSD. The presence of ZnT1 in the vast majority of excitatory synapses in hippocampus suggests an unanticipated basic role for ZnT1 in synaptic function that warrants further investigation.
Materials and methods
Rabbit anti-ZnT1 antibodies were obtained from William F. Silverman (Ben-Gurion University). The specificity of the antibody, raised against the carboxyl-tail of mouse ZnT1 , was previously demonstrated by transfection of HEK-293 cells with mouse ZnT1 plasmid, and by siRNA-mediated knockdown in rat cortical neurons . Rabbit anti-GluR1 antibody, mouse anti-PSD95, and mouse anti-actin were from Millipore; rabbit anti-SynGAP was from Affinity Bioreagents.
All procedures followed present regulations for animal care and handling and were approved by the University of Barcelona Ethical Committee. BALB/c mice (2 month-old) were anesthesized and perfused with heparinized saline, and 4% formaldehyde/0.1% glutaraldehyde in 0.1 M phosphate buffer (PB; pH 7.4). Brains were postfixed for 2 hr, cryoprotected in 30% sucrose in PB, frozen, and cut into 40 μm-thick sections. Brain slices were freeze-thawed twice with liquid N2, rinsed in PB, incubated in 0.5% NaBH4 in PB for 15 min, and blocked in 10% NGS, 1% BSA and 0.2 M glycine in PBS for 2 hr. Slices were incubated in rabbit anti-ZnT1 antibody (1:500) at 4°C for 2 d, then rinsed and incubated in biotinylated goat anti-rabbit IgG (1:200) at 4°C for 8 hr, rinsed again, and incubated in streptavidin-biotinylated HRP (1:300). The HRP was developed in 0.05% DAB and 0.001% H2O2 in Tris–HCl buffer.
Hippocampi were collected from postnatal day 1 pups, digested with 10 U/ml papain in Hank’s buffer, dissociated, and plated in Neurobasal A with supplements on poly-D-lysine-coated coverslips. Cultures were fixed with 4% formaldehyde, 4% sucrose in PB, and then 100% methanol for 10 min at 4°C. Tyramide-Cyanine 3 signal amplification was used according to manufacturer instructions (Perkin Elmer) to detect binding of anti-GluR1 (1:6,000) or anti-SynGAP (1:8,000) antibodies. Immunolabeling with anti-ZnT1 antibodies (1:500) was detected with goat anti-rabbit Alexa488 IgG. Images were captured using an Olympus Fluoview FV600 confocal microscope and x63 objectives. Z-series of 4 consecutive optical sections (0.6 μm) were acquired using sequential scanning and Kalman filter.
Hippocampi were homogenized in 10 volumes of buffer containing 10 mM HEPES, pH 7.5, 0.32 M sucrose, 2 mM EDTA, 2 mM EGTA, 5 mM DTT, and protease inhibitor cocktail tablet (Roche), followed by centrifugation at 800 g for 10 min. Supernatants were saved as the cytoplamic fraction. Pellets were resuspended in homogenization buffer plus 0.5% Nonidet P-40, and centrifuged again to obtain crude nuclear fractions. These nuclear fractions were resuspended in extraction buffer containing 10 mM HEPES, pH 7.5, 400 mM NaCl, 10% glycerol, 0.5% Nonidet P-40, 2 mM EDTA, 2 mM EGTA, 5 mM DTT, and protease inhibitor cocktail. Suspensions were rocked for 30 min on ice and centrifuged at 16,700 g for 10 min. Resulting supernatants were used as nuclear extracts. The cytoplasmic fraction was centrifuged (10,200 g, 15 min) to obtain the crude synaptosomal pellet, resuspended with 0.5% Triton, rocked, and centrifuged at 21,000 g for 40 min. The PSD-enriched pellet was resuspended in LB. The supernatant containing non-PSD membranes was precipitated with -20°C acetone. Equal protein amounts were separated by SDS-PAGE in 8% gels. PVDF membranes were blocked with 5% BSA, 0.1% Tween-20 in Tris-buffered saline (TBS), and incubated overnight at 4°C with ZnT1 antibodies (1:1,000), or 1 h at RT with PSD-95 (1:10,000) or actin (1:5,000) antibodies. Proteins were detected with HRP-conjugated secondary antibodies and visualized by chemiluminescence.
Post-embedding immunoelectron microscopy
For acrylic embedding, brains from two Wistar rats (250–300 g) were perfused with 4% formaldehyde, 0.2% glutaraldehyde and 0.2% picric acid in PB, pH 7.4. Vibratome slices were cryoprotected in glycerol, frozen in liquid propane, freeze-substituted in 0.5% uranyl acetate in methanol at -90°C, infiltrated with Lowicryl HM20 at -45°C, and polymerized with UV light. For Zn2+ staining and epoxy embedding, we used our previous protocol (Sindreu’03). Briefly, two rats were perfused with 0.1% Na2S and 2.5% glutaraldehyde in PB, followed by 1% formaldehyde, 2.5% glutaraldehyde and 0.2% picric acid. Slices were stained with the Neo-Timm’s method (Danscher, 1981), post-fixed using an osmium-free protocol (Phend et al., 1995) and flat-embedded in epoxy resin (Embed-812; EMS). Lowicryl or epoxy sections (60–70 nm) were collected on gold grids (200 mesh), incubated in 0.5% NaBH4 in 50 mM Tris-buffered saline (TBS; pH = 7.6) for 10 min, rinsed in 0.005% Tergitol NP-10 in TBS (TBST), blocked in 10% NGS, 2% BSA and 50 mM glycine in TBST, and reacted with anti-ZnT1 antibodies (1:200) overnight. Grids were rinsed in TBST and TBST/pH 8.2, and incubated in 10 nm gold-conjugated goat anti-rabbit F(ab)2 fragments (1:30; British BioCell) for 2 h. Grids were rinsed and counterstained.
Electron micrographs were taken at × 30,000 magnification, recorded by a CCD camera (Gatan Inc.) and analysed with Canvas software (Deneba Systems, Inc.). The CA1 stratum radiatum was examined by random systematic sampling of visual fields (1/3) at 10–200 μm from the pyramidal cell layer. Synapses were defined as those structures showing synaptic vesicles in the presynaptic element and a postsynaptic membrane specialization. Labeling at the synaptic junction was analysed in transversely cut synaptic profiles. To assess the transversal location of synaptic gold particles, we measured the distance from the outer margin of the postsynaptic junctional membrane to the center of each gold particle in a line perpendicular to the membrane. Particles were considered ‘synaptic’ when found within a radius of 30 nm from the postsynaptic junctional membrane, and ‘extrasynaptic’ when located further away. Similarly, a 30 nm limit was used to differentiate between surface and intracellular labeling. To assess the tangential location of particles, the distance of each gold particle from the centre of the PSD was normalized to the half-length of the PSD profile. PSD lengths shorter than 200 nm were excluded for tangential analysis. To calculate the surface density, gold particles in each membrane compartment were counted in digital EM pictures, and effective membrane lengths measured. Double staining for vesicular Zn2+ and ZnT1 was studied in synapses located within 4 μm from the net surface of the vibratome slice to avoid false negative counts . T-test and ANOVA were used for pair-wise and multiple comparisons, respectively. Significance was set at 0.05. Data are given as mean ± standard error of mean unless otherwise noted.
We thank Zeev Silverman for the gift of ZnT1 antibodies. This work was supported by the Fundacio Marato de TV3. CS and AB are supported by the Ramon y Cajal Research Career Program. XA is supported by the Miguel Servet Research Career Program.
- Sindreu C, Storm DR: Modulation of neuronal signal transduction and memory formation by synaptic zinc. Front Behav Neurosci. 2011, 5: 68-PubMedPubMed CentralView ArticleGoogle Scholar
- Sensi SL, Paoletti P, Koh JY, Aizenman E, Bush AI, Hershfinkel M: The neurophysiology and pathology of brain zinc. J Neurosci. 2011, 31: 16076-16085. 10.1523/JNEUROSCI.3454-11.2011.PubMedPubMed CentralView ArticleGoogle Scholar
- Huang L, Tepaamorndech S: The SLC30 family of zinc transporters - a review of current understanding of their biological and pathophysiological roles. Mol Aspects Med. 2013, 34: 548-560. 10.1016/j.mam.2012.05.008.PubMedView ArticleGoogle Scholar
- Carter RE, Aiba I, Dietz RM, Sheline CT, Shuttleworth CW: Spreading depression and related events are significant sources of neuronal Zn2+ release and accumulation. J Cereb Blood Flow Metab. 2011, 31: 1073-1084. 10.1038/jcbfm.2010.183.PubMedPubMed CentralView ArticleGoogle Scholar
- Lee JY, Cole TB, Palmiter RD, Koh JY: Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J Neurosci. 2000, 20: RC79-PubMedGoogle Scholar
- Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW: The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. 1996, 272: 1013-1016. 10.1126/science.272.5264.1013.PubMedView ArticleGoogle Scholar
- Lee JY, Son HJ, Choi JH, Cho E, Kim J, Chung SJ, Hwang O, Koh JY: Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment. Brain Res. 2009, 1286: 208-214.PubMedView ArticleGoogle Scholar
- Jan HH, Chen IT, Tsai YY, Chang YC: Structural role of zinc ions bound to postsynaptic densities. J Neurochem. 2002, 83: 525-534. 10.1046/j.1471-4159.2002.01093.x.PubMedView ArticleGoogle Scholar
- Baron MK, Boeckers TM, Vaida B, Faham S, Gingery M, Sawaya MR, Salyer D, Gundelfinger ED, Bowie JU: An architectural framework that may lie at the core of the postsynaptic density. Science. 2006, 311: 531-535. 10.1126/science.1118995.PubMedView ArticleGoogle Scholar
- Grabrucker AM, Knight MJ, Proepper C, Bockmann J, Joubert M, Rowan M, Nienhaus GU, Garner CC, Bowie JU, Kreutz MR, Gundelfinger ED, Boeckers TM: Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J. 2011, 30: 569-581. 10.1038/emboj.2010.336.PubMedPubMed CentralView ArticleGoogle Scholar
- El-Husseini AE, Topinka JR, Lehrer-Graiwer JE, Firestein BL, Craven SE, Aoki C, Bredt DS: Ion channel clustering by membrane-associated guanylate kinases. Differential regulation by N-terminal lipid and metal binding motifs. J Biol Chem. 2000, 275: 23904-23910. 10.1074/jbc.M909919199.PubMedView ArticleGoogle Scholar
- Cole TB, Wenzel HJ, Kafer KE, Schwartzkroin PA, Palmiter RD: Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci USA. 1999, 96: 1716-1721. 10.1073/pnas.96.4.1716.PubMedPubMed CentralView ArticleGoogle Scholar
- Palmiter RD, Findley SD: Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 1995, 14: 639-649.PubMedPubMed CentralGoogle Scholar
- Sekler I, Moran A, Hershfinkel M, Dori A, Margulis A, Birenzweig N, Nitzan Y, Silverman WF: Distribution of the zinc transporter ZnT-1 in comparison with chelatable zinc in the mouse brain. J Comp Neurol. 2002, 447: 201-209. 10.1002/cne.10224.PubMedView ArticleGoogle Scholar
- Sindreu CB, Varoqui H, Erickson JD, Pérez-Clausell J: Boutons containing vesicular zinc define a subpopulation of synapses with low AMPAR content in rat hippocampus. Cereb Cortex. 2003, 13: 823-829. 10.1093/cercor/13.8.823.PubMedView ArticleGoogle Scholar
- Grabrucker S, Jannetti L, Eckert M, Gaub S, Chhabra R, Pfaender S, Mangus K, Reddy PP, Rankovic V, Schmeisser MJ, Kreutz MR, Ehret G, Boeckers TM, Grabrucker AM: Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders. Brain. 2014, 137: 137-152. 10.1093/brain/awt303.PubMedView ArticleGoogle Scholar
- Qian J, Xu K, Yoo J, Chen TT, Andrews G, Noebels JL: Knockout of Zn transporters Zip-1 and Zip-3 attenuates seizure-induced CA1 neurodegeneration. J Neurosci. 2011, 31: 97-104. 10.1523/JNEUROSCI.5162-10.2011.PubMedPubMed CentralView ArticleGoogle Scholar
- Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, Reynolds IJ: Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem. 2000, 75: 1878-1888.PubMedView ArticleGoogle Scholar
- Knapp LT, Klann E: Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem. 2000, 275: 24136-24145. 10.1074/jbc.M002043200.PubMedView ArticleGoogle Scholar
- Lee JY, Kim JH, Palmiter RD, Koh JY: Zinc released from metallothionein-iii may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury. Exp Neurol. 2003, 184: 337-347. 10.1016/S0014-4886(03)00382-0.PubMedView ArticleGoogle Scholar
- Jirakulaporn T, Muslin AJ: Cation diffusion facilitator proteins modulate Raf-1 activity. J Biol Chem. 2004, 279: 27807-27815. 10.1074/jbc.M401210200.PubMedView ArticleGoogle Scholar
- Levy S, Beharier O, Etzion Y, Mor M, Buzaglo L, Shaltiel L, Gheber LA, Kahn J, Muslin AJ, Katz A, Gitler D, Moran A: Molecular basis for zinc transporter 1 action as an endogenous inhibitor of L-type calcium channels. J Biol Chem. 2009, 284: 32434-32443. 10.1074/jbc.M109.058842.PubMedPubMed CentralView ArticleGoogle Scholar
- Andrews GK, Wang H, Dey SK, Palmiter RD: Mouse zinc transporter 1 gene provides an essential function during early embryonic development. Genesis. 2004, 40: 74-81. 10.1002/gene.20067.PubMedView ArticleGoogle Scholar
- Ohana E, Sekler I, Kaisman T, Kahn N, Cove J, Silverman WF, Amsterdam A, Hershfinkel M: Silencing of ZnT-1 expression enhances heavy metal influx and toxicity. J Mol Med. 2006, 84: 753-763. 10.1007/s00109-006-0062-4.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.